Status:
COMPLETED
Cross-linked CMC and Silk Proteins in Eye Disease
Lead Sponsor:
D&V FARMA srl
Collaborating Sponsors:
San Giovanni Addolorata Hospital
Conditions:
Dry Eye Disease (DED)
Eligibility:
All Genders
18+ years
Brief Summary
Data analyses and revision of the DED symptoms. A novel ophthalmic solution containing cross-linked CMC (CX-CMC) and Silk Proteins (SP) has been made available on the market. Both molecules have been...
Eligibility Criteria
Inclusion
- Subjects affected by dry eye disease
Exclusion
- know allergies to CX-CMC
- know allergies to SP
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06605365
Start Date
September 1 2021
End Date
September 1 2022
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Giovanni-Addolorata Hospital
Rome, Italy, 00184